Each pharmaceutical compound has its own characteristics and formulation challenges. InnoCore has many years of experience and case studies tailoring sustained release technologies to meet the requirements of a large variety of compounds.
InnoCore has patented technologies suitable for a variety of compounds. By entrapment in a polymer matrix, the API can be protected from degradation.
Robert Hof joined InnoCore as Chief Executive Officer in June 2023. Previous to joining InnoCore, Robert worked in various...
Read moreRob Steendam, is Co-Founder and Chief Technology Officer at InnoCore. He holds an MSc degree in polymer chemistry and a PhD...
Read moreMartin Bakker, Chief Business Officer since 2015. In the past, he worked for several companies in Management & Director roles...
Read moreMonika Tyl joined InnoCore in May 2023 and is responsible for the Quality Department in the position of Director Quality and...
Read moreDirk Jan van Drooge joined Innocore as Director Development in November 2023 to lead the Formulation and Process Development...
Read moreDirector Operations since 2022 and Manager of the Analytical (as of 2012) and the Polymer R&D Department. Wilma is...
Read moreJohan Zuidema joined InnoCore in 2009, working in different roles in Technology Development, Process Development and since 2014...
Read moreAiva Simaite has joined InnoCore as a Project Manager in 2022. She holds a PhD in Micro-/Nanofabrication and has extensive...
Read moreThanh Nguyen is a Project Manager at InnoCore. Thanh joined InnoCore in 2014 and since then has developed his career in project...
Read moreAnastasia joined InnoCore as a Project Manager in March 2023. Before joining InnoCore, Anastasia was working as a Lead Scientist...
Read more